I-Mab : FDA Oks IND To Initiate Phase 1 Study For Protollin For Treatment Of Alzheimer's Disease
30/7 14:32
(RTTNews) - The U.S. Food and Drug Administration has cleared the Investigational New Drug submission for Protollin, an investigational drug to treat Alzheimer's disease, enabling a Phase 1 clinical trial to be initiated, I-Mab (IMAB) said in a statement....